The Capsule That Made Researchers Stop Guessing
Vitamin D deficiency affects an estimated one billion people worldwide, and most of them have no idea because the symptoms disguise themselves as ordinary fatigue, seasonal mood shifts, and the kind of bone aches people blame on getting older. Bio-Tech Pharmacal built their reputation on a single molecule: cholecalciferol. Their D3-50, a 50,000 IU clinical-strength capsule, became the product that endocrinologists and researchers at institutions like Mayo Clinic and Memorial Sloan Kettering actually used in studies. Not referenced. Used.
The range spans from 1,000 IU daily maintenance all the way to 50,000 IU weekly repletion protocols, each capsule manufactured in an FDA-registered pharmaceutical facility in Fayetteville, Arkansas. The D3-K2 combination pairs cholecalciferol with MK-7 because calcium needs a traffic cop, and K2 is the one nutrient qualified to direct it away from arteries and toward bones. The D3 Plus formula adds co-factors that support absorption for patients whose serum levels stubbornly resist standard supplementation.
Every bottle in this line contains one active ingredient per capsule (two in the combination formulas, clearly labeled). No proprietary blends masking underdosed nutrients behind a curtain. No trendy additions that dilute the thing you came here for. The label reads like a short sentence because it is one.
When the clinical world needed a vitamin D source trustworthy enough to attach their institutional names to published research, they chose the capsule from Arkansas. Forty years later, the formula has not changed because it did not need to. That is what happens when you get it right the first time.
